Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.

Tytuł :
Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
Autorzy :
Kerbl R; University Children's Hospital (Division of Hematology/Oncology), Graz, Austria.
Urban CE
Ladenstein R
Ambros IM
Spuller E
Mutz I
Amann G
Kovar H
Gadner H
Ambros PF
Pokaż więcej
Źródło :
Medical and pediatric oncology [Med Pediatr Oncol] 1997 Jul; Vol. 29 (1), pp. 1-10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Język :
English
Imprint Name(s) :
Publication: New York, NY : Wiley-Liss
Original Publication: New York, Liss.
MeSH Terms :
Mass Screening*
Neuroblastoma/*diagnosis
Age Factors ; Austria/epidemiology ; Humans ; Incidence ; Infant ; Neoplasm Staging ; Neuroblastoma/epidemiology ; Neuroblastoma/pathology ; Neuroblastoma/prevention & control
Entry Date(s) :
Date Created: 19970701 Date Completed: 19970520 Latest Revision: 20190905
Update Code :
20210210
DOI :
10.1002/(sici)1096-911x(199707)29:1<1::aid-mpo1>3.0.co;2-j
PMID :
9142198
Czasopismo naukowe
Background: Encouraged by Japanese reports of the benefits of screening 6 month-old infants for neuroblastoma, a neuroblastoma screening program was introduced in Austria in 1991. However, because of concerns related to "overdiagnosis" by screening at this age, the screening test was performed at a later age.
Methods: From March 1991 to February 1995 neuroblastoma screening was performed on filter paper urine specimens in 100,043 Austrian infants (median age 8.5 months). Primary analysis of urine catecholamines (vanillylmandelic acid and homovanillic acid was performed by use of an E1A method. Questionable or positive results were confirmed by high performance liquid chromatography (HPLC). A double retest was requested following a positive HPLC result.
Results: Twenty-one infants were admitted to a hospital following repeatedly elevated values of vanillymandelic acid (VMA) and/or homovanillic acid (HVA). Eleven infants were found to have neuroblastoma (three stage 1, four stage 2B, four stage 3). Treatment consisted of surgery alone with total or subtotal resection in eight cases, surgery and chemotherapy in two cases, and chemotherapy alone in one case. Biologic features were assessed in all tumors excluding ploidy in one case. The majority of the tumors analyzed were near-triploid (9/10), however, two tumors revealed N-myc amplification.
Conclusions: Our results demonstrate that stage distribution and biologic features of neuroblastomas diagnosed by screening at 8.5 months are different from the results of screening at 6 months. Furthermore, the detection of one neuroblastoma among 9,100 screened infants is significantly lower than the incidence of the Japanese screening program. Our results suggest that screening at an age of 7 to 10 months reduces overdiagnosis and may be of more benefit than earlier screening.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies